Case Report: Lamin A/C Gene Mutation in Patient with Drug-induced Type 1 Brugada Syndrome at High Arrhythmic Risk

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2023 Jan 27

PMID 36704457

Authors

Vincenzo Russo

Giovanni Papaccioli

Valeria Maddaloni

Adriano Caputo

Nicola Pepe

Anna Rago

Michele Maiorino

Paolo Golino

Gerardo Nigro

Affiliations

Soon will be listed here.

Abstract

We report the case of drug-induced type 1 Brugada syndrome at high arrhythmic risk associated with Lamin A/C gene mutation.

Citing Articles

The Prognostic Role of Programmed Ventricular Stimulation in the Risk Stratification of Sudden Cardiac Death.

Iavarone M, Rago A, Molinari R, DAndrea A, Nesti M, Muscoli S Rev Cardiovasc Med. 2024; 24(5):152.

PMID: 39076736 PMC: 11273013. DOI: 10.31083/j.rcm2405152.

Syncope without prodromes during fever in type 1-induced BrS patient: Looks can be deceiving.

Russo V, Limatola M, De Santis Ciacci C, Mauriello A J Arrhythm. 2023; 39(4):661-663.

PMID: 37560293 PMC: 10407185. DOI: 10.1002/joa3.12889.

References

Francisco A, Santos Goncalves I, Veiga F, Mendes Pedro M, Pinto F, Brito D . Complex phenotype linked to a mutation in exon 11 of the lamin A/C gene: Hypertrophic cardiomyopathy, atrioventricular block, severe dyslipidemia and diabetes. Rev Port Cardiol. 2017; 36(9):669.e1-669.e4. DOI: 10.1016/j.repc.2016.07.018. View

Letsas K, Vlachos K, Conte G, Efremidis M, Nakashima T, Duchateau J . Right ventricular outflow tract electroanatomical abnormalities in asymptomatic and high-risk symptomatic patients with Brugada syndrome: Evidence for a new risk stratification tool?. J Cardiovasc Electrophysiol. 2021; 32(11):2997-3007. DOI: 10.1111/jce.15262. View

Taylor M, Fain P, Sinagra G, Robinson M, Robertson A, Carniel E . Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol. 2003; 41(5):771-80. DOI: 10.1016/s0735-1097(02)02954-6. View

Rattanawong P, Kewcharoen J, Kanitsoraphan C, Vutthikraivit W, Putthapiban P, Prasitlumkum N . The utility of drug challenge testing in Brugada syndrome: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2020; 31(9):2474-2483. DOI: 10.1111/jce.14631. View

Glikson M, Nielsen J, Kronborg M, Michowitz Y, Auricchio A, Barbash I . 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2021; 24(1):71-164. DOI: 10.1093/europace/euab232. View

Armaroli A, Balla C, Trabanelli C, Selvatici R, Brieda A, Sette E . Lamin A/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and Laminopathies. Circ Genom Precis Med. 2020; 13(2):e002751. DOI: 10.1161/CIRCGEN.119.002751. View

Salvarani N, Crasto S, Miragoli M, Bertero A, Paulis M, Kunderfranco P . The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy. Nat Commun. 2019; 10(1):2267. PMC: 6531493. DOI: 10.1038/s41467-019-09929-w. View

Russo V, Pafundi P, Caturano A, Dendramis G, Ghidini A, Santobuono V . Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study. JACC Clin Electrophysiol. 2021; 7(10):1264-1273. DOI: 10.1016/j.jacep.2021.03.010. View

Barc J, Tadros R, Glinge C, Chiang D, Jouni M, Simonet F . Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. Nat Genet. 2022; 54(3):232-239. PMC: 9376964. DOI: 10.1038/s41588-021-01007-6. View

10.

Pieroni M, Notarstefano P, Oliva A, Campuzano O, Santangeli P, Coll M . Electroanatomic and Pathologic Right Ventricular Outflow Tract Abnormalities in Patients With Brugada Syndrome. J Am Coll Cardiol. 2018; 72(22):2747-2757. DOI: 10.1016/j.jacc.2018.09.037. View